Related Experiment Video

Updated: Jul 18, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.7K

ZCCHC4 Promotes Osteosarcoma Progression by Upregulating ITGB1

Lingli Luo1, Xiaojun Tang2, Linghua Liu3

  • 1Medical College, Hunan Polytechnic of Environment and Biology, Hengyang 421005, Hunan Province, China.

Critical Reviews in Eukaryotic Gene Expression
|August 22, 2023
PubMed

Insights

Zinc finger CCHC-type containing 4 (ZCCHC4) promotes osteosarcoma progression by upregulating integrin β1. Inhibiting ZCCHC4 may offer a new therapeutic strategy for osteosarcoma patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Zinc finger CCHC-type containing 4 (ZCCHC4) is an RNA-binding protein involved in rRNA methylation and tumor cell proliferation.
  • The specific role of ZCCHC4 in osteosarcoma (OS) pathogenesis has not been previously elucidated.

Purpose of the Study:

  • To investigate the function and mechanism of ZCCHC4 in the progression of osteosarcoma.
  • To determine if ZCCHC4 could serve as a potential therapeutic target for OS.

Main Methods:

  • Quantitative real-time PCR and Western blotting were used to assess ZCCHC4 expression in OS tissues and cell lines.
  • Cell proliferation, epithelial-mesenchymal transition (EMT), and migration assays were performed following ZCCHC4 overexpression or knockdown.
  • Animal models were utilized to evaluate the in vivo effects of ZCCHC4 on tumor growth and metastasis.

Main Results:

  • ZCCHC4 exhibited significantly higher expression in osteosarcoma tissues and cell lines compared to normal controls.
  • ZCCHC4 overexpression enhanced OS cell proliferation, EMT, and motility, while ZCCHC4 silencing inhibited these processes.
  • ZCCHC4 was found to upregulate integrin β1 (ITGB1) expression, mediating its pro-tumorigenic effects.
  • In vivo studies demonstrated that ZCCHC4 knockdown suppressed osteosarcoma tumor growth and reduced metastasis.

Conclusions:

  • ZCCHC4 plays a critical role in promoting osteosarcoma progression, at least partly through the upregulation of ITGB1.
  • Targeting ZCCHC4 represents a promising novel therapeutic strategy for the treatment of osteosarcoma.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.4K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K